Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

[Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels].

Smulders MW, Bekkers SCAM, van Cauteren YJM, Liefhebber A, Vermeer JR, Vervuurt J, van Dieijen-Visser MP, Mingels AMA, Brunner-La Rocca HP, Dagnelie PC, Wildberger JE, Crijns HJGM, Kietselaer BLJH.

Ned Tijdschr Geneeskd. 2018 Dec 5;162. pii: D3568. Dutch.

PMID:
30570937
2.

Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels.

Smulders MW, Bekkers SCAM, van Cauteren YJM, Liefhebber A, Vermeer JR, Vervuurt J, van Dieijen-Visser MP, Mingels AMA, Brunner-La Rocca HP, Dagnelie PC, Wildberger JE, Crijns HJGM, Kietselaer BLJH.

PLoS One. 2018 Sep 7;13(9):e0203506. doi: 10.1371/journal.pone.0203506. eCollection 2018.

3.

Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.

van der Linden N, Wildi K, Twerenbold R, Pickering JW, Than M, Cullen L, Greenslade J, Parsonage W, Nestelberger T, Boeddinghaus J, Badertscher P, Rubini Giménez M, Klinkenberg LJJ, Bekers O, Schöni A, Keller DI, Sabti Z, Puelacher C, Cupa J, Schumacher L, Kozhuharov N, Grimm K, Shrestha S, Flores D, Freese M, Stelzig C, Strebel I, Miró Ò, Rentsch K, Morawiec B, Kawecki D, Kloos W, Lohrmann J, Richards AM, Troughton R, Pemberton C, Osswald S, van Dieijen-Visser MP, Mingels AM, Reichlin T, Meex SJR, Mueller C.

Circulation. 2018 Sep 4;138(10):989-999. doi: 10.1161/CIRCULATIONAHA.117.032003.

4.

Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study.

Kimenai DM, Martens RJH, Kooman JP, Stehouwer CDA, Tan FES, Schaper NC, Dagnelie PC, Schram MT, van der Kallen CJH, Sep SJS, van Suijlen JDE, Kroon AA, Bekers O, van Dieijen-Visser MP, Henry RMA, Meex SJR.

Sci Rep. 2017 Jul 26;7(1):6610. doi: 10.1038/s41598-017-06978-3.

5.

Estimated Glomerular Filtration Rate and Albuminuria Are Associated with Biomarkers of Cardiac Injury in a Population-Based Cohort Study: The Maastricht Study.

Martens RJ, Kimenai DM, Kooman JP, Stehouwer CD, Tan FE, Bekers O, Dagnelie PC, van der Kallen CJ, Kroon AA, Leunissen KM, van der Sande FM, Schaper NC, Sep SJ, Schram MT, van Suijlen JD, van Dieijen-Visser MP, Meex SJ, Henry RM.

Clin Chem. 2017 Apr;63(4):887-897. doi: 10.1373/clinchem.2016.266031. Epub 2017 Feb 17.

6.

Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.

Mingels AM, Cardinaels EP, Broers NJ, van Sleeuwen A, Streng AS, van Dieijen-Visser MP, Kooman JP, Bekers O.

Clin Chem. 2017 Mar;63(3):683-690. doi: 10.1373/clinchem.2016.261644. Epub 2017 Jan 10.

7.

Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction.

Streng AS, de Boer D, van Doorn WP, Bouwman FG, Mariman EC, Bekers O, van Dieijen-Visser MP, Wodzig WK.

Clin Chem. 2017 Feb;63(2):563-572. doi: 10.1373/clinchem.2016.261511. Epub 2016 Dec 9.

8.

Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction.

Klinkenberg LJ, Wildi K, van der Linden N, Kouw IW, Niens M, Twerenbold R, Rubini Gimenez M, Puelacher C, Daniel Neuhaus J, Hillinger P, Nestelberger T, Boeddinghaus J, Grimm K, Sabti Z, Bons JA, van Suijlen JD, Tan FE, Ten Kate J, Bekers O, van Loon LJ, van Dieijen-Visser MP, Mueller C, Meex SJ.

Clin Chem. 2016 Dec;62(12):1602-1611. Epub 2016 Oct 5.

9.

[Real change or natural fluctuation?]

Hilderink JM, Koopmans RP, Rennenberg RJ, van Dieijen-Visser MP, Meex SJ.

Ned Tijdschr Geneeskd. 2016;160:D132. Dutch.

PMID:
27677234
10.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

11.

Strong diurnal rhythm of troponin T, but not troponin I, in a patient with renal dysfunction.

van der Linden N, Cornelis T, Klinkenberg LJ, Kimenai DM, Hilderink JM, Litjens EJ, Kooman JP, Bekers O, van Dieijen-Visser MP, Meex SJ.

Int J Cardiol. 2016 Oct 15;221:287-8. doi: 10.1016/j.ijcard.2016.06.268. Epub 2016 Jun 28. No abstract available.

PMID:
27404692
12.

Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging?

Smulders MW, Kietselaer BL, Schalla S, Bucerius J, Jaarsma C, van Dieijen-Visser MP, Mingels AM, Rocca HP, Post M, Das M, Crijns HJ, Wildberger JE, Bekkers SC.

Am Heart J. 2016 Jul;177:102-11. doi: 10.1016/j.ahj.2016.03.025. Epub 2016 Apr 30. Review.

13.

Cardiac Troponin T and I Release After a 30-km Run.

Klinkenberg LJ, Luyten P, van der Linden N, Urgel K, Snijders DP, Knackstedt C, Dennert R, Kietselaer BL, Mingels AM, Cardinaels EP, Peeters FE, van Suijlen JD, Ten Kate J, Marsch E, Theelen TL, Sluimer JC, Wouters K, Bekers O, Bekkers SC, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

Am J Cardiol. 2016 Jul 15;118(2):281-7. doi: 10.1016/j.amjcard.2016.04.030. Epub 2016 May 4.

14.

High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well?

Cardinaels EP, Altintas S, Versteylen MO, Joosen IA, Jellema LJ, Wildberger JE, Das M, Crijns HJ, Bekers O, van Dieijen-Visser MP, Kietselaer BL, Mingels AM.

PLoS One. 2016 Apr 20;11(4):e0153300. doi: 10.1371/journal.pone.0153300. eCollection 2016.

15.

Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T.

Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK.

Data Brief. 2016 Mar 3;7:397-405. doi: 10.1016/j.dib.2016.02.051. eCollection 2016 Jun.

16.

Direct comparison of clinical decision limits for cardiac troponin T and I.

Kimenai DM, Henry RM, van der Kallen CJ, Dagnelie PC, Schram MT, Stehouwer CD, van Suijlen JD, Niens M, Bekers O, Sep SJ, Schaper NC, van Dieijen-Visser MP, Meex SJ.

Heart. 2016 Apr;102(8):610-6. doi: 10.1136/heartjnl-2015-308917. Epub 2016 Jan 21.

PMID:
26794233
17.

Development of a targeted selected ion monitoring assay for the elucidation of protease induced structural changes in cardiac troponin T.

Streng AS, de Boer D, Bouwman FG, Mariman EC, Scholten A, van Dieijen-Visser MP, Wodzig WK.

J Proteomics. 2016 Mar 16;136:123-32. doi: 10.1016/j.jprot.2015.12.028. Epub 2016 Jan 6.

PMID:
26772903
18.

Heart failure in nursing home residents; a cross-sectional study to determine the prevalence and clinical characteristics.

Daamen MA, Hamers JP, Gorgels AP, Brunner-La Rocca HP, Tan FE, van Dieijen-Visser MP, Schols JM.

BMC Geriatr. 2015 Dec 16;15:167. doi: 10.1186/s12877-015-0166-1.

19.

The effect of exercise training on the course of cardiac troponin T and I levels: three independent training studies.

van der Linden N, Klinkenberg LJ, Leenders M, Tieland M, Verdijk LB, Niens M, van Suijlen JD, de Groot LC, Bekers O, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

Sci Rep. 2015 Dec 16;5:18320. doi: 10.1038/srep18320.

20.

Unstable coronary plaque characteristics are associated with high-sensitivity cardiac troponin T and N-terminal Pro-Brain Natriuretic Peptide.

Altintas S, Cardinaels EP, Versteylen MO, Joosen IA, Seifert M, Wildberger JE, Crijns HJ, Nelemans PJ, Van Dieijen-Visser MP, Mingels AM, Das M, Kietselaer BL.

J Cardiovasc Comput Tomogr. 2016 Jan-Feb;10(1):82-8. doi: 10.1016/j.jcct.2015.10.001. Epub 2015 Oct 10.

PMID:
26481512
21.

Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents.

Cardinaels EP, Daamen MA, Bekers O, ten Kate J, Niens M, van Suijlen JD, van Dieijen-Visser MP, Brunner-La Rocca HP, Schols JM, Mingels AM.

J Am Med Dir Assoc. 2015 Oct 1;16(10):884-91. doi: 10.1016/j.jamda.2015.06.026. Epub 2015 Aug 6.

PMID:
26255708
22.

Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins.

Cardinaels EP, Cornelis T, van der Sande FM, Leunissen KM, van Dieijen-Visser MP, Mingels AM, Kooman JP, Bekers O.

Clin Chem Lab Med. 2015 Oct;53(11):e289-92. doi: 10.1515/cclm-2015-0201. No abstract available.

PMID:
26011925
23.

Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.

Eurlings LW, Sanders-van Wijk S, van Kraaij DJ, van Kimmenade R, Meeder JG, Kamp O, van Dieijen-Visser MP, Tijssen JG, Brunner-La Rocca HP, Pinto YM.

J Card Fail. 2014 Dec;20(12):881-90. doi: 10.1016/j.cardfail.2014.08.014. Epub 2014 Aug 28.

24.

The effect of a six-month resistance-type exercise training program on the course of high sensitive cardiac troponin T levels in (pre)frail elderly.

van der Linden N, Tieland M, Klinkenberg LJ, Verdijk LB, de Groot LC, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

Int J Cardiol. 2014 Aug 1;175(2):374-5. doi: 10.1016/j.ijcard.2014.05.017. Epub 2014 May 16. No abstract available.

PMID:
24874909
25.

Cardiac troponin in ischemic cardiomyocytes: intracellular decrease before onset of cell death.

Streng AS, Jacobs LH, Schwenk RW, Cardinaels EP, Meex SJ, Glatz JF, Wodzig WK, van Dieijen-Visser MP.

Exp Mol Pathol. 2014 Jun;96(3):339-45. doi: 10.1016/j.yexmp.2014.02.012. Epub 2014 Mar 4.

PMID:
24607416
26.

Circulating cardiac troponin T exhibits a diurnal rhythm.

Klinkenberg LJ, van Dijk JW, Tan FE, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

J Am Coll Cardiol. 2014 May 6;63(17):1788-95. doi: 10.1016/j.jacc.2014.01.040. Epub 2014 Feb 26.

27.

The role of cardiovascular magnetic resonance imaging and computed tomography angiography in suspected non-ST-elevation myocardial infarction patients: design and rationale of the CARdiovascular Magnetic rEsoNance imaging and computed Tomography Angiography (CARMENTA) trial.

Smulders MW, Kietselaer BL, Das M, Wildberger JE, Crijns HJ, Veenstra LF, Brunner-La Rocca HP, van Dieijen-Visser MP, Mingels AM, Dagnelie PC, Post MJ, Gorgels AP, van Asselt AD, Vogel G, Schalla S, Kim RJ, Bekkers SC.

Am Heart J. 2013 Dec;166(6):968-75. doi: 10.1016/j.ahj.2013.09.012. Epub 2013 Oct 23.

28.

Effect of antioxidant supplementation on exercise-induced cardiac troponin release in cyclists: a randomized trial.

Klinkenberg LJ, Res PT, Haenen GR, Bast A, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

PLoS One. 2013 Nov 19;8(11):e79280. doi: 10.1371/journal.pone.0079280. eCollection 2013.

29.

Posttranslational modifications of cardiac troponin T: an overview.

Streng AS, de Boer D, van der Velden J, van Dieijen-Visser MP, Wodzig WK.

J Mol Cell Cardiol. 2013 Oct;63:47-56. doi: 10.1016/j.yjmcc.2013.07.004. Epub 2013 Jul 18. Review.

PMID:
23871791
30.

Time-dependent degradation pattern of cardiac troponin T following myocardial infarction.

Cardinaels EP, Mingels AM, van Rooij T, Collinson PO, Prinzen FW, van Dieijen-Visser MP.

Clin Chem. 2013 Jul;59(7):1083-90. doi: 10.1373/clinchem.2012.200543. Epub 2013 Mar 27.

31.

Characterization of the perfusate proteome of human donor kidneys.

Snoeijs MG, Pulinx B, van Dieijen-Visser MP, Buurman WA, van Heurn LW, Wodzig WK.

Ann Clin Biochem. 2013 Mar;50(Pt 2):140-6. doi: 10.1258/acb.2012.011144. Epub 2013 Feb 21.

PMID:
23431486
32.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).

Hammerer-Lercher A, Collinson P, van Dieijen-Visser MP, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem Lab Med. 2013 Jun;51(6):1301-6. doi: 10.1515/cclm-2012-0510.

PMID:
23334056
33.

Detection of differential protein expression in cerebrospinal fluid of patients with multiple sclerosis through two-dimensional differential in gel electrophoresis.

Pulinx B, Hupperts RM, Vogt MH, ten Kate J, van Dieijen-Visser MP, Wodzig WK.

Clin Chem Lab Med. 2012;50(9):1693-5. doi: 10.1515/cclm-2012-0011. No abstract available.

PMID:
23089612
34.

[Cardiac troponin].

Mingels AM, Gorgels TP, van Dieijen-Visser MP.

Ned Tijdschr Geneeskd. 2012;156(42):A5044. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2012;156(42):A5044.

PMID:
23075777
35.

Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.

de Jager SC, Bongaerts BW, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S, van Dieijen-Visser MP, Cleutjens KB, Nelemans PJ, van Berkel TJ, Biessen EA.

PLoS One. 2012;7(9):e45804. doi: 10.1371/journal.pone.0045804. Epub 2012 Sep 21.

36.

Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score.

Eurlings LW, Sanders-van Wijk S, van Kimmenade R, Osinski A, van Helmond L, Vallinga M, Crijns HJ, van Dieijen-Visser MP, Brunner-La Rocca HP, Pinto YM.

J Am Coll Cardiol. 2012 Oct 23;60(17):1668-77. doi: 10.1016/j.jacc.2012.06.040. Epub 2012 Sep 26.

37.

Time- and temperature-dependent stability of troponin standard reference material 2921 in serum and plasma.

Mingels AM, Cobbaert CM, de Jong N, van den Hof WF, van Dieijen-Visser MP.

Clin Chem Lab Med. 2012 Mar 30;50(9):1681-4. doi: 10.1515/cclm-2011-1851. No abstract available.

PMID:
22962230
38.

The prevalence and management of heart failure in Dutch nursing homes; design of a multi-centre cross-sectional study.

Daamen MA, Hamers JP, Gorgels AP, Brunner-la Rocca HP, Tan FE, van Dieijen-Visser MP, Schols JM.

BMC Geriatr. 2012 Jun 11;12:29. doi: 10.1186/1471-2318-12-29.

39.

A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead.

Cardinaels EP, Mingels AM, Jacobs LH, Meex SJ, Bekers O, van Dieijen-Visser MP.

Clin Chem Lab Med. 2012 Mar 16;50(5):791-806. doi: 10.1515/cclm-2011-0895. Review.

PMID:
22628325
40.

Strong link between basal and exercise-induced cardiac troponin T levels: do both reflect risk?

Klinkenberg LJ, Res PT, van Loon LJ, van Dieijen-Visser MP, Meex SJ.

Int J Cardiol. 2012 Jun 28;158(1):129-31. doi: 10.1016/j.ijcard.2012.04.050. Epub 2012 May 3. No abstract available.

PMID:
22560936
41.

High-sensitivity cardiac troponin T: risk stratification tool in patients with symptoms of chest discomfort.

Mingels AM, Joosen IA, Versteylen MO, Laufer EM, Winkens MH, Wildberger JE, Van Dieijen-Visser MP, Hofstra L.

PLoS One. 2012;7(4):e35059. doi: 10.1371/journal.pone.0035059. Epub 2012 Apr 25.

42.

Circulating biomarkers and abdominal aortic aneurysm size.

Hellenthal FA, Pulinx B, Welten RJ, Teijink JA, van Dieijen-Visser MP, Wodzig WK, Schurink GW.

J Surg Res. 2012 Aug;176(2):672-8. doi: 10.1016/j.jss.2011.09.040. Epub 2011 Oct 11.

PMID:
22169593
43.

Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea.

van Wijk S, Jacobs L, Eurlings LW, van Kimmenade R, Lemmers R, Broos P, Bekers O, Prins MH, Crijns HJ, Pinto YM, van Dieijen-Visser MP, Brunner-La Rocca HP.

Clin Chem. 2012 Jan;58(1):284-92. doi: 10.1373/clinchem.2011.175976. Epub 2011 Nov 18.

44.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

45.

Differential protein expression in serum of abdominal aortic aneurysm patients - a proteomic approach.

Pulinx B, Hellenthal FA, Hamulyák K, van Dieijen-Visser MP, Schurink GW, Wodzig WK.

Eur J Vasc Endovasc Surg. 2011 Nov;42(5):563-70. doi: 10.1016/j.ejvs.2011.07.019. Epub 2011 Aug 16.

46.

Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratio.

Jacobs LH, Mingels AM, Wodzig WK, van Dieijen-Visser MP, Kooman JP.

Am J Clin Pathol. 2010 Sep;134(3):516-7; author reply 517. doi: 10.1309/AJCPIZHTDSR2OGGX. No abstract available.

PMID:
20716809
47.

The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T.

Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, Wildberger JE, Narula J, Van Dieijen-Visser MP, Hofstra L.

Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1269-75. doi: 10.1161/ATVBAHA.109.200394. Epub 2010 Mar 18.

PMID:
20299689
48.

Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance.

Mingels AM, Jacobs LH, Kleijnen VW, Laufer EM, Winkens B, Hofstra L, Wodzig WK, van Dieijen-Visser MP.

Clin Res Cardiol. 2010 Jun;99(6):385-91. doi: 10.1007/s00392-010-0134-x. Epub 2010 Mar 8.

PMID:
20213264
49.

Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.

Jacobs LH, van de Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, van der Sande FM, Wodzig WK, Konings CJ, Leunissen KM, van Dieijen-Visser MP, Kooman JP.

Nephrol Dial Transplant. 2010 Jan;25(1):243-8. doi: 10.1093/ndt/gfp417. Epub 2009 Aug 19.

PMID:
19692417
50.

Pharmacogenetic testing after a simple DNA isolation method on buccal swab samples.

Wijnen PA, Drent M, van Dieijen-Visser MP, Bekers O.

Pharmacogenomics. 2009 Jun;10(6):983-7. doi: 10.2217/pgs.09.4.

PMID:
19530965

Supplemental Content

Loading ...
Support Center